FDA authorizes Pfizer COVID-19 vaccine booster shot for older and high-risk Americans

The Food and Drug Administration (FDA) on Wednesday authorized booster shots of Pfizer’s COVID-19 vaccine for people aged 65 and older, as well as for certain others at high risk of severe disease.